Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending August 10, 2024 (Week 32)
Reporting Area Carbapenemase-Producing Organisms (CPO), Total §,¶
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 37 NC 2,373 3,646
New England - NC 33 33
Connecticut - NC - -
Maine - NC 2 -
Massachusetts - NC - -
New Hampshire - NC 10 14
Rhode Island - NC 21 19
Vermont - NC - -
Middle Atlantic 1 NC 83 340
New Jersey - NC - -
New York (excluding New York City) - NC - -
New York City - NC - 138
Pennsylvania 1 NC 83 202
East North Central 18 NC 1,177 1,496
Illinois - NC 11 461
Indiana - NC 181 242
Michigan 2 NC 93 194
Ohio 16 NC 892 575
Wisconsin - NC - 24
West North Central - NC 81 148
Iowa - NC 27 53
Kansas - NC 50 52
Minnesota - NC - 38
Missouri - NC - -
Nebraska - NC - -
North Dakota - NC - 4
South Dakota - NC 4 1
South Atlantic 8 NC 330 500
Delaware - NC 13 10
District of Columbia - NC - -
Florida N NC N N
Georgia - NC - 195
Maryland - NC - -
North Carolina - NC - 100
South Carolina - NC - -
Virginia 8 NC 258 151
West Virginia - NC 59 44
East South Central - NC - 109
Alabama N NC N N
Kentucky - NC - -
Mississippi - NC - 109
Tennessee - NC - -
West South Central - NC - 14
Arkansas - NC - -
Louisiana - NC - 14
Oklahoma - NC - -
Texas U NC U U
Mountain 9 NC 653 503
Arizona 9 NC 639 482
Colorado - NC - -
Idaho - NC - -
Montana - NC 5 1
Nevada - NC 1 6
New Mexico - NC - -
Utah - NC 8 13
Wyoming - NC - 1
Pacific 1 NC 16 503
Alaska - NC - -
California - NC - 467
Hawaii - NC - 5
Oregon 1 NC 16 13
Washington - NC - 18
U.S. Territories - NC - 113
American Samoa - NC - -
Commonwealth of Northern Mariana Islands - NC - -
Guam - NC - -
Puerto Rico - NC - 113
U.S. Virgin Islands - NC - -
Non-U.S. Residents - NC 2 -
Total 37 NC 2,375 3,759
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2023, cases began to be reported as Carbapenemase-Producing Organisms, clinical or Carbapenemase-Producing Organisms, screening. In previous years, only Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) cases were reported.
  • ¶ CPO (total) includes CP-CRE cases reported in MMWR year 2023, and CPO clinical and CPO screening cases reported in both MMWR years 2023 and 2024.